Anti-CCN6/ LIBC/ PPAC functional antibody

Anti-CCN6/ LIBC/ PPAC functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCN6/CCN6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T23655-Ab-1/ GM-Tg-hg-T23655-Ab-2Anti-Human CCN6 monoclonal antibodyHuman
GM-Tg-rg-T23655-Ab-1/ GM-Tg-rg-T23655-Ab-2Anti-Rat CCN6 monoclonal antibodyRat
GM-Tg-mg-T23655-Ab-1/ GM-Tg-mg-T23655-Ab-2Anti-Mouse CCN6 monoclonal antibodyMouse
GM-Tg-cynog-T23655-Ab-1/ GM-Tg-cynog-T23655-Ab-2Anti-Cynomolgus/ Rhesus macaque CCN6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T23655-Ab-1/ GM-Tg-felg-T23655-Ab-2Anti-Feline CCN6 monoclonal antibodyFeline
GM-Tg-cang-T23655-Ab-1/ GM-Tg-cang-T23655-Ab-2Anti-Canine CCN6 monoclonal antibodyCanine
GM-Tg-bovg-T23655-Ab-1/ GM-Tg-bovg-T23655-Ab-2Anti-Bovine CCN6 monoclonal antibodyBovine
GM-Tg-equg-T23655-Ab-1/ GM-Tg-equg-T23655-Ab-2Anti-Equine CCN6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T23655-Ab-1/ GM-Tg-hg-T23655-Ab-2; GM-Tg-rg-T23655-Ab-1/ GM-Tg-rg-T23655-Ab-2;
GM-Tg-mg-T23655-Ab-1/ GM-Tg-mg-T23655-Ab-2; GM-Tg-cynog-T23655-Ab-1/ GM-Tg-cynog-T23655-Ab-2;
GM-Tg-felg-T23655-Ab-1/ GM-Tg-felg-T23655-Ab-2; GM-Tg-cang-T23655-Ab-1/ GM-Tg-cang-T23655-Ab-2;
GM-Tg-bovg-T23655-Ab-1/ GM-Tg-bovg-T23655-Ab-2; GM-Tg-equg-T23655-Ab-1/ GM-Tg-equg-T23655-Ab-2
Products NameAnti-CCN6 monoclonal antibody
Formatmab
Target NameCCN6
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCN6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T23655-Ag-1Recombinant multi-species CCN6/ LIBC/ PPAC protein
    CytokineGM-Tg-g-T23655-Ag-1WNT1 inducible signaling pathway protein 3 (WISP3) protein
    ORF Viral VectorpGMLP000776human WISP3 Lentivirus plasmid
    ORF Viral VectorvGMLP000776human WISP3 Lentivirus particle
    ORF Viral VectorpGMLPm003970mouse Wisp3 Lentivirus plasmid
    ORF Viral VectorvGMLPm003970mouse Wisp3 Lentivirus particle


    Target information

    Target IDGM-T23655
    Target NameCCN6
    Gene ID8838,327743,499461,695430,100686448,101086230,100849041,100072430
    Gene Symbol and SynonymsCCN6,Gm735,LIBC,PPAC,PPD,PPRD,RGD1564120,WISP-3,WISP3
    Uniprot AccessionO95389
    Uniprot Entry NameCCN6_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000112761
    Target ClassificationN/A

    The target: CCN6, gene name: CCN6, also named as LIBC, PPAC, PPD, WISP-3, WISP3. This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like domain. This gene is overexpressed in colon tumors. It may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Mutations of this gene are associated with progressive pseudorheumatoid dysplasia, an autosomal recessive skeletal disorder, indicating that the gene is essential for normal postnatal skeletal growth and cartilage homeostasis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.